# Metformin Treatment in Infants After Perinatal Brain Injury

> **NCT05590676** · PHASE1 · TERMINATED · sponsor: **The Hospital for Sick Children** · enrollment: 1 (actual)

## Conditions studied

- Hypoxic Ischemic Encephalopathy of Newborn
- Premature Birth

## Interventions

- **DRUG:** Metformin Hydrochloride

## Key facts

- **NCT ID:** NCT05590676
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-05-02
- **Primary completion:** 2024-02-22
- **Final completion:** 2024-02-22
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Low recruitment
- **Last updated:** 2024-03-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05590676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05590676, "Metformin Treatment in Infants After Perinatal Brain Injury". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05590676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
